Rhenman & Partners Asset Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$4.3M	–	98
2024 Q4	$4.3M	Sell	50,000 -50,000	-50%	-$4.3M	0.44%	58
2024 Q3	$11.9M	Buy	+100,000	New	+$11.9M	0.97%	35
2017 Q4	–	Sell	-160,000	Closed	-$3.85M	–	98
2017 Q3	$3.85M	Buy	+160,000	New	+$3.85M	0.49%	67